Hope For Stomach Cancer is another nonprofit organization that offers resources to patients, caregivers, and loved ones while promoting early detection and prevention in different communities (including medical and nonmedical). The organization develops and rolls out programs to assist stomach cancer patients to live the best possible life throughout the phases of the disease. Therefore, a rising number of gastric cancer awareness programs are expected to offer lucrative opportunities for the Middle East & Africa gastric cancer diagnostic procedures market during the forecast period.
The Middle East & Africa gastric cancer diagnostic procedure market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Countries in this region report varied incidences of gastric cancer. According to the latest WHO data published in 2020, deaths caused due to stomach cancer reached 389 or 0.29% of total deaths in Saudi Arabia. Moreover, Dyspepsia, a type of gastrointestinal disease, is common across the country. Saudi Arabia records the highest prevalence of dyspepsia in the Gulf, which can potentially lead to more GI complications, poor health, and deteriorating national outcomes. According to an article published in 2019 by Saudi Journal of Gastroenterology, the prevalence rate of H. pylori in Saudi Arabia was reported to be in the range of 50–80% among symptomatic patients with dyspepsia and abdominal pain or in patients undergoing endoscopic procedures. According to an article published in 2021, the prevalence of H. pylori in Saudi Arabia was 71.33% in patients suffering from different biopsy-proven GI conditions, such as gastritis, peptic ulcer disease, and gastric cancer. An upsurge in the number of gastric/stomach cancer, ulcer disease, and GI condition cases favors the overall growth of the gastric cancer diagnostic procedure market.
Middle East & Africa Gastric Cancer Diagnostic Procedure Market Segmentation
The Middle East & Africa gastric cancer diagnostic procedure market is segmented into healthcare providers, symptom types, body fluid, procedures, offerings, disease indication, and country.
Based on healthcare providers, the Middle East & Africa gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. The Hospitals segment held the largest gastric cancer diagnostic procedure market share in 2022.
Based on symptoms type, the South & Central America gastric cancer diagnostic procedure market is segmented into symptomatic and asymptomatic. The Asymptomatic segment held largest Middle East & Africa gastric cancer diagnostic procedure market share in 2022.
Based on body fluid, The Middle East & Africa gastric cancer diagnostic procedure market is segmented into Blood, urine, saliva, stomach wash/gastric juice, tissue and others. Blood segment held largest Middle East & Africa gastric cancer diagnostic procedure market share in 2022.
Based on offering, the Middle East & Africa gastric cancer diagnostic procedure market is segmented into Instruments, Reagents & Consumables and Services. Reagents & Consumables segment held the Middle East & Africa gastric cancer diagnostic procedure market share in 2022.
Based on Diagnostic procedure, the Middle East & Africa gastric cancer diagnostic procedure market is categorized into Endoscopic procedure, Biopsy and tissue tests, lab test, In-vitro diagnostic tests, Imaging Test, Molecular Diagnostics, Multiplexing molecular Diagnostics, Immunoassay, and others. The imaging segment held largest Middle East & Africa gastric cancer diagnostic procedure market share in 2022.
Based on disease condition, the Middle East & Africa gastric cancer diagnostic procedure market is segmented into Early Gastric cancer and Gastric cancer advanced types. The Gastric cancer advanced type segment held larger Middle East & Africa gastric cancer diagnostic procedure market share in 2022.
Based on country, the Middle East & Africa gastric cancer diagnostic procedure market has been segmented into Saudi Arabia, South Africa, the UAE, and Rest of the Middle East & Africa. Saudi Arabia dominated the market in this region in 2022.
Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd; bioMerieux SA; Thermo Fisher Scientific Inc; Illumina Inc; and Vela Diagnostics Holding Pte Ltd. are the leading companies operating in the Middle East & Africa gastric cancer diagnostic procedure market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 39.63 Million |
| Market Size by 2028 | US$ 51.05 Million |
| CAGR (2022 - 2028) | 4.3 % |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Healthcare Providers
|
|
Regions and Countries Covered
|
|
| Middle East and Africa | South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa |
| Market leaders and key company profiles |
|
The Middle East & Africa Gastric Cancer Diagnostic Procedure Market is valued at US$ 39.63 Million in 2022, it is projected to reach US$ 51.05 Million by 2028.
As per our report Middle East & Africa Gastric Cancer Diagnostic Procedure Market, the market size is valued at US$ 39.63 Million in 2022, projecting it to reach US$ 51.05 Million by 2028. This translates to a CAGR of approximately 4.3 % during the forecast period.
The Middle East & Africa Gastric Cancer Diagnostic Procedure Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Gastric Cancer Diagnostic Procedure Market report:
The Middle East & Africa Gastric Cancer Diagnostic Procedure Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Gastric Cancer Diagnostic Procedure Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Gastric Cancer Diagnostic Procedure Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)